Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Vera García, R"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Artajo,J. de Carlos, Castro Unanua,N., Muruzábal Huarte,E., Vera García,R., Irigaray Echarri,A., Zubiría Gortázar,J., Anda Apiñániz,E.
Publikováno v:
Anales del Sistema Sanitario de Navarra v.43 n.1 2020
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen Everolimus es un inhibidor de mTOR, empleado en oncología y como inmunosupresor en el trasplante de órgano sólido. Sus efectos adversos a nivel metabólico son muy frecuentes, especialmente los más severos. Puede ocasionar hiperglucemia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::03c2725239ab5bde9bcd96a60dd79456
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272020000100013
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272020000100013
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Arraras Urdaniz, J.I., Illarramendi Mañas, J.J., Manterola Burgaleta, A., Tejedor Gutiérrez, M., Vera García, R., Valerdi Álvarez, J.J., Domínguez Domínguez, M.A.
Publikováno v:
In Revista clinica espanola 2003 203(12):577-581
Autor:
Suárez-Llanos JP; Clinical Nutrition and Dietetics Unit, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain., Vera-García R; Medical Oncology Department, Hospital Universitario de Navarra, Irunlarrea 3, 31008 Pamplona, Spain., Contreras-Martinez J; Radiation Oncology Department, Hospital Regional de Málaga, 29009 Málaga, Spain.
Publikováno v:
Nutrients [Nutrients] 2022 Mar 28; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 28.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valerdi Alvarez Jj, Manterola Burgaleta A, Vera García R, Illarramendi Mañas Jj, Tejedor Gutiérrez M, Domínguez Domínguez Ma, Arraras Urdaniz Ji
Publikováno v:
Revista Clínica Española. 230:577-581
BASIS: The objective of the present work is to evaluate the quality of life of a group of patients with breast cancer after a long follow-up time. METHODS: 104 patients with breast cancer in initial stages, of a total of 125 to whom the questionnaire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cf6a88fbbc2f7973e1fcd6911e3fdb9
https://doi.org/10.1157/13053726
https://doi.org/10.1157/13053726
Autor:
Derksen JWG; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Warren GW; Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC, USA., Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Heidelberg, Germany., Rauh S; Department of Oncology, Centre Hospitalier Emile Mayrisch, Esch-sur-Alzette, Luxembourg., Vera García R; Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain., O'Mahony D; Department of Medical Oncology, Cork University Hospital, Cork, Ireland., Ahmed S; Department of Medical Oncology, University Hospitals of Leicester, Leicester, UK., Vuylsteke P; Department of Medical Oncology, UCLouvain, CHU Namur, Belgium; Faculty of Medicine, University of Botswana, Gaborone, Botswana., Radulovic S; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Tsoukalas N; Department of Oncology, 401 General Military Hospital of Athens, Athens, Greece., Wysocki PJ; Department of Oncology, Jagiellonian University - Medical College, Cracow, Poland., Borner M; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland., Cesas A; Department of Medical Oncology, Klaipeda University Hospital, Klaipeda, Lithuania., Elme A; Department of Oncology and Hematology, North Estonia Medical Centre Foundation, Tallinn, Estonia., Minn H; Department of Oncology, Turku University Hospital, Turku, Finland., Ullenhag GJ; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Science of Life Laboratory, Uppsala University, Uppsala, Sweden., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: a.m.may@umcutrecht.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Oct; Vol. 138, pp. 99-108. Date of Electronic Publication: 2020 Aug 29.
Autor:
Muñoz Martín AJ; Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain., Jiménez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Avenida Roma, 33011, Oviedo, Spain. palucaji@hotmail.com., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Muñoz Langa J; Medical Oncology Department, Hospital Universitario Clínico de Valencia, Valencia, Spain., Pérez Segura P; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Rodríguez Lescure A; Medical Oncology Department, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Hospital General Universitario de Elche, Elche, Spain., Vera García R; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Aug; Vol. 22 (8), pp. 1423-1424. Date of Electronic Publication: 2019 Dec 23.